San Diego's Vital Therapies Names Ex-Jazz Pharma Exec as New Chief Leader
Cox takes over for Vital Therapies CEO Terry Winters who will step down from the Vital Therapies Board and become a consultant to the company. Source: BioSpace
Investigation Leads SoCal's Avanir to Quietly Lay Off 73 Employees
Avanir terminated about 11 percent of its sales force after CNN filed a report showing how the company paid 500 prescribers about $14M over three years for prescribers to tout…
How Cambridge Biotech Akcea Teaches Its 80 Employees to Put a Human Face on Illnesses
The company wants staffers to get a taste of life with a super-rare metabolic disorder. An actual taste. Source: BioSpace
Bay Area's Carmot Lands $240M+ R&D Tie-Up With Biotech Giant Amgen
Under the deal, Carmot will use its lead-identification technology to identify and advance novel drug leads for Parkinson's disease and other disease areas. Source: BioSpace
Amazon Yanks Pharma License App in Maine
Amazon didn't immediately respond to a request for comment. Source: BioSpace
Judge Allows Suit Against Compounder for Overcharging TRICARE to Go Ahead
A Florida federal judge ruled Monday that the federal government’s False Claims Act complaint against a compounding pharmacy can proceed. Source: Drug Industry Daily
Sanofi and J&J Rank Highest in Clinical Trial Transparency: Study
Drugmakers have improved at clinical trial transparency compared to 2015, with Sanofi and Johnson & Johnson sharing first place in a transparency ranking sponsored by Bioethics International. Source: Drug Industry…
FDA Breakthrough Designations Can Knock Off Three Years of Development, Study Finds
Admission to the FDA’s expedited programs can shave years off clinical development times, according to a new analysis. Source: Drug Industry Daily
International Drugmakers Plan for More Manufacturing, Testing Costs as Brexit Looms
Testifying before a UK House of Commons committee Tuesday, international pharmaceutical companies said they are already hedging their bets when it comes to the real-world consequences of Brexit, making preparations…
Lexicon Pharma Secures Up to $200M Non-Dilutive Term Loan Financing
The first $150 million is available immediately and an additional tranche of $50 million is available for draw by March 2019. Source: BioSpace
- Go to the previous page
- 1
- …
- 237
- 238
- 239
- 240
- 241
- 242
- 243
- …
- 610
- Go to the next page